(CNX) CNX Resources - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US12653C1080
Stock: Natural Gas, Shale, CBM, Gathering, Processing
Total Rating 54
Risk 69
Buy Signal 0.12
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 32.4% |
| Relative Tail Risk | 0.44% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.05 |
| Alpha | 29.80 |
| Character TTM | |
|---|---|
| Beta | 0.430 |
| Beta Downside | 0.542 |
| Drawdowns 3y | |
|---|---|
| Max DD | 33.37% |
| CAGR/Max DD | 1.06 |
Description: CNX CNX Resources January 09, 2026
CNX Resources Corp (NYSE:CNX) is an independent natural-gas and midstream operator focused on the Appalachian Basin. It extracts shale gas in PA, WV, OH and shallow formations in the Midwest, while also producing coal-bed methane (CBM) across several states, including NM. The firm owns ~2,700 mi of gathering pipelines and associated processing facilities, and it provides turnkey water-management services to its own fields and third-party operators.
Key operating metrics (2023): ≈ 1.9 billion cubic feet per day (Bcf/d) of gas production, ≈ $1.2 billion of operating cash flow, and a net debt-to-EBITDA ratio of ~2.1×. The company benefits from the U.S. natural-gas price spread between Henry Hub and regional pipeline points, which has averaged a $0.45/MMBtu premium in 2023, and from the expanding LNG export pipeline capacity that supports long-term demand for domestic gas supplies.
For a deeper, data-driven assessment of CNX’s valuation and risk profile, you may find the analytics on ValueRay worth a quick look.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 633.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 2.64 > 1.0 |
| NWC/Revenue: -28.07% < 20% (prev -55.87%; Δ 27.80% < -1%) |
| CFO/TA 0.11 > 3% & CFO 1.03b > Net Income 633.2m |
| Net Debt (2.45b) to EBITDA (1.53b): 1.60 < 3 |
| Current Ratio: 0.44 > 1.5 & < 3 |
| Outstanding Shares: last quarter (154.5m) vs 12m ago 2.13% < -2% |
| Gross Margin: 72.79% > 18% (prev 0.60%; Δ 7219 % > 0.5%) |
| Asset Turnover: 25.66% > 50% (prev 15.81%; Δ 9.84% > 0%) |
| Interest Coverage Ratio: 5.40 > 6 (EBITDA TTM 1.53b / Interest Expense TTM 176.6m) |
Altman Z'' 1.42
| A: -0.07 (Total Current Assets 490.3m - Total Current Liabilities 1.12b) / Total Assets 9.09b |
| B: 0.22 (Retained Earnings 1.98b / Total Assets 9.09b) |
| C: 0.11 (EBIT TTM 953.2m / Avg Total Assets 8.80b) |
| D: 0.42 (Book Value of Equity 1.98b / Total Liabilities 4.76b) |
| Altman-Z'' Score: 1.42 = BB |
Beneish M -2.73
| DSRI: 0.98 (Receivables 325.9m/197.4m, Revenue 2.26b/1.35b) |
| GMI: 0.82 (GM 72.79% / 59.90%) |
| AQI: 1.05 (AQ_t 0.08 / AQ_t-1 0.08) |
| SGI: 1.68 (Revenue 2.26b / 1.35b) |
| TATA: -0.04 (NI 633.2m - CFO 1.03b) / TA 9.09b) |
| Beneish M-Score: -2.73 (Cap -4..+1) = A |
What is the price of CNX shares?
As of February 07, 2026, the stock is trading at USD 40.27 with a total of 1,883,985 shares traded.
Over the past week, the price has changed by +3.79%, over one month by +11.03%, over three months by +17.44% and over the past year by +38.05%.
Over the past week, the price has changed by +3.79%, over one month by +11.03%, over three months by +17.44% and over the past year by +38.05%.
Is CNX a buy, sell or hold?
CNX Resources has received a consensus analysts rating of 2.46.
Therefor, it is recommend to sell CNX.
- StrongBuy: 1
- Buy: 0
- Hold: 6
- Sell: 3
- StrongSell: 3
What are the forecasts/targets for the CNX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 36.2 | -10.1% |
| Analysts Target Price | 36.2 | -10.1% |
| ValueRay Target Price | 52.8 | 31.1% |
CNX Fundamental Data Overview January 31, 2026
P/E Trailing = 9.7487
P/E Forward = 16.6667
P/S = 2.5012
P/B = 1.2346
P/EG = 0.96
Revenue TTM = 2.26b USD
EBIT TTM = 953.2m USD
EBITDA TTM = 1.53b USD
Long Term Debt = 1.84b USD (from longTermDebt, last fiscal year)
Short Term Debt = 213.2m USD (from shortTermDebt, last quarter)
Debt = 2.45b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.45b USD (from netDebt column, last quarter)
Enterprise Value = 8.05b USD (5.60b + Debt 2.45b - CCE 779.0k)
Interest Coverage Ratio = 5.40 (Ebit TTM 953.2m / Interest Expense TTM 176.6m)
EV/FCF = 15.08x (Enterprise Value 8.05b / FCF TTM 534.0m)
FCF Yield = 6.63% (FCF TTM 534.0m / Enterprise Value 8.05b)
FCF Margin = 23.64% (FCF TTM 534.0m / Revenue TTM 2.26b)
Net Margin = 28.03% (Net Income TTM 633.2m / Revenue TTM 2.26b)
Gross Margin = 72.79% ((Revenue TTM 2.26b - Cost of Revenue TTM 614.6m) / Revenue TTM)
Gross Margin QoQ = 93.18% (prev 35.93%)
Tobins Q-Ratio = 0.89 (Enterprise Value 8.05b / Total Assets 9.09b)
Interest Expense / Debt = 1.71% (Interest Expense 42.0m / Debt 2.45b)
Taxrate = 12.55% (28.2m / 224.4m)
NOPAT = 833.7m (EBIT 953.2m * (1 - 12.55%))
Current Ratio = 0.44 (Total Current Assets 490.3m / Total Current Liabilities 1.12b)
Debt / Equity = 0.57 (Debt 2.45b / totalStockholderEquity, last quarter 4.34b)
Debt / EBITDA = 1.60 (Net Debt 2.45b / EBITDA 1.53b)
Debt / FCF = 4.59 (Net Debt 2.45b / FCF TTM 534.0m)
Total Stockholder Equity = 4.08b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.19% (Net Income 633.2m / Total Assets 9.09b)
RoE = 15.52% (Net Income TTM 633.2m / Total Stockholder Equity 4.08b)
RoCE = 16.11% (EBIT 953.2m / Capital Employed (Equity 4.08b + L.T.Debt 1.84b))
RoIC = 12.58% (NOPAT 833.7m / Invested Capital 6.63b)
WACC = 5.67% (E(5.60b)/V(8.05b) * Re(7.50%) + D(2.45b)/V(8.05b) * Rd(1.71%) * (1-Tc(0.13)))
Discount Rate = 7.50% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -9.02%
[DCF Debug] Terminal Value 85.68% ; FCFF base≈430.6m ; Y1≈404.1m ; Y5≈376.9m
Fair Price DCF = 62.33 (EV 11.33b - Net Debt 2.45b = Equity 8.88b / Shares 142.4m; r=5.90% [WACC]; 5y FCF grow -7.86% → 2.90% )
EPS Correlation: 25.27 | EPS CAGR: -4.43% | SUE: 0.40 | # QB: 0
Revenue Correlation: -41.10 | Revenue CAGR: -5.58% | SUE: 0.04 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.72 | Chg30d=-0.023 | Revisions Net=-4 | Analysts=7
EPS current Year (2026-12-31): EPS=2.80 | Chg30d=+0.106 | Revisions Net=-5 | Growth EPS=+11.7% | Growth Revenue=-11.2%
EPS next Year (2027-12-31): EPS=4.29 | Chg30d=-0.053 | Revisions Net=-1 | Growth EPS=+53.2% | Growth Revenue=+13.6%
P/E Forward = 16.6667
P/S = 2.5012
P/B = 1.2346
P/EG = 0.96
Revenue TTM = 2.26b USD
EBIT TTM = 953.2m USD
EBITDA TTM = 1.53b USD
Long Term Debt = 1.84b USD (from longTermDebt, last fiscal year)
Short Term Debt = 213.2m USD (from shortTermDebt, last quarter)
Debt = 2.45b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.45b USD (from netDebt column, last quarter)
Enterprise Value = 8.05b USD (5.60b + Debt 2.45b - CCE 779.0k)
Interest Coverage Ratio = 5.40 (Ebit TTM 953.2m / Interest Expense TTM 176.6m)
EV/FCF = 15.08x (Enterprise Value 8.05b / FCF TTM 534.0m)
FCF Yield = 6.63% (FCF TTM 534.0m / Enterprise Value 8.05b)
FCF Margin = 23.64% (FCF TTM 534.0m / Revenue TTM 2.26b)
Net Margin = 28.03% (Net Income TTM 633.2m / Revenue TTM 2.26b)
Gross Margin = 72.79% ((Revenue TTM 2.26b - Cost of Revenue TTM 614.6m) / Revenue TTM)
Gross Margin QoQ = 93.18% (prev 35.93%)
Tobins Q-Ratio = 0.89 (Enterprise Value 8.05b / Total Assets 9.09b)
Interest Expense / Debt = 1.71% (Interest Expense 42.0m / Debt 2.45b)
Taxrate = 12.55% (28.2m / 224.4m)
NOPAT = 833.7m (EBIT 953.2m * (1 - 12.55%))
Current Ratio = 0.44 (Total Current Assets 490.3m / Total Current Liabilities 1.12b)
Debt / Equity = 0.57 (Debt 2.45b / totalStockholderEquity, last quarter 4.34b)
Debt / EBITDA = 1.60 (Net Debt 2.45b / EBITDA 1.53b)
Debt / FCF = 4.59 (Net Debt 2.45b / FCF TTM 534.0m)
Total Stockholder Equity = 4.08b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.19% (Net Income 633.2m / Total Assets 9.09b)
RoE = 15.52% (Net Income TTM 633.2m / Total Stockholder Equity 4.08b)
RoCE = 16.11% (EBIT 953.2m / Capital Employed (Equity 4.08b + L.T.Debt 1.84b))
RoIC = 12.58% (NOPAT 833.7m / Invested Capital 6.63b)
WACC = 5.67% (E(5.60b)/V(8.05b) * Re(7.50%) + D(2.45b)/V(8.05b) * Rd(1.71%) * (1-Tc(0.13)))
Discount Rate = 7.50% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -9.02%
[DCF Debug] Terminal Value 85.68% ; FCFF base≈430.6m ; Y1≈404.1m ; Y5≈376.9m
Fair Price DCF = 62.33 (EV 11.33b - Net Debt 2.45b = Equity 8.88b / Shares 142.4m; r=5.90% [WACC]; 5y FCF grow -7.86% → 2.90% )
EPS Correlation: 25.27 | EPS CAGR: -4.43% | SUE: 0.40 | # QB: 0
Revenue Correlation: -41.10 | Revenue CAGR: -5.58% | SUE: 0.04 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.72 | Chg30d=-0.023 | Revisions Net=-4 | Analysts=7
EPS current Year (2026-12-31): EPS=2.80 | Chg30d=+0.106 | Revisions Net=-5 | Growth EPS=+11.7% | Growth Revenue=-11.2%
EPS next Year (2027-12-31): EPS=4.29 | Chg30d=-0.053 | Revisions Net=-1 | Growth EPS=+53.2% | Growth Revenue=+13.6%